Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
59.47
+2.66 (4.67%)
At close: Jul 3, 2025, 1:00 PM
59.57
+0.10 (0.18%)
After-hours: Jul 3, 2025, 1:00 PM EDT
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $1.94 billion as of July 3, 2025. Its market cap has increased by 30.96% in one year.
Market Cap
1.94B
Enterprise Value
1.79B
1-Year Change
30.96%
Ranking
Category
Stock Price
$59.47
Market Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $1.94B, an increase of 1,238.62%. That is a compound annual growth rate of 126.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 1.94B | -0.68% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 699.59B |
| Johnson & Johnson | 374.29B |
| AbbVie | 336.94B |
| Novo Nordisk | 309.43B |
| UnitedHealth Group | 279.00B |
| Novartis AG | 243.28B |
| Abbott Laboratories | 233.33B |
| AstraZeneca | 219.33B |